Lovastatin Tablet
Product Images NDC 66267-561

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 66267-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 561 90

66267 561 90
uCare Pharmaceuticals, Inc. manufactures Lovastatin 40mg tablets with 90 tablets in each pack. The tablets are white/off-white, round-shaped, and engraved with CTi 143 on one side. The product's lot number is 000000 and the NDC codes are 66267-561-90 and 66267-0561-90. The manufacturer's NDC code is 61442-143-01, and the tablets' expiry date is 00-00. The packaging includes a warning to keep the medicine out of children's reach and store it at a controlled temperature of 68-77°F. The text mentions the potential side effects of the medication and advises consumers to report them to the FDA using the contact information provided.*
FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
This appears to be a graph or figure titled "Proportion of Participants Without Event" with a focus on "Acute Major Coronary Events" as the primary endpoint. The x-axis represents "Years of Follow-up" and the y-axis appears to indicate the proportion of participants without an event. No further information is available.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
This is a table of drug interactions that are associated with an increased risk of Myopathy/Rhabdomyolysis. Prescribing recommendations are also given. Strong CYP3A4 inhibitors, HIV protease inhibitors, and Cobicistat-containing products are contraindicated with lovastatin. Gemfibrozil should be avoided with lovastatin. Cyclosporine, Danazol, Difiazem, and Dronedarone should not exceed 20 mg lovastatin daily. Also, do not exceed 40 mg lovastatin daily. Grapefruit juice should be avoided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.